Echo IQ has developed a cloud-based tool that gives an AI-powered assessment of risk of structural heart disease, called EchoSolv, to bring treatment closer to patients and reduce the risk of misdiagnosis.
Conditions assessed include;
This proprietary digital (cloud-based) solution is backed by the latest in medical technology, AI and machine learning. Our innovative diagnostic tool is designed to show probability indicators for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound and will analyze this data to generate a risk indicator. This will be augmented by an additional checks, as defined by the current AHA guidelines.
We provide extra layers of protection to reduce the risk of negative reputation or litigation risks because of missed diagnosis. Not only does our solution protect patients, but it protects doctors and healthcare workers too.
USER FRIENDLY TECHNOLOGY
EchoSolv platform is securely built to align with HIPAA and SOC 2 Controls.
INCREASED OPPORTUNITIES TO TREAT APPROPRIATE PATIENTS
By reducing the risk of misdiagnosis, you’re provided with more opportunities to identify patients and treat those who need it most.
IMPROVED PATIENT OUTCOMES
Eliminate subjectivity in your echo analysis and the number of missed opportunities and inconsistencies. Enjoy fast, accurate and improved diagnosis that benefits both patient and doctor. Essentially, our cutting-edge diagnostic tools take the element of human error out of the diagnostic process and ensure that nothing is missed. This reduces the rate of misdiagnoses and can be life-saving.
Contact Us Today